Solexa posts narrowed Q3 loss
13th Nov 2006, 22:28 GMT
Solexa reported a narrowed Q3 loss just as the Hayward biotech company announced its acquisition by San Diego-based Illumina Solexa reported a net loss of $9.9 mln, or $0.27 per share, for Q3 ended 9/30/2006 compared with a net loss of $10.8 mln, or $0.43 per share, for the same quarter in 2005.
Solexa posts narrowed Q3 loss related news:
- Solexa posts narrowed Q3 loss — Latest news from East Bay Business Times
- Solexa Narrows 3Q Loss — Bio-Technology News from StratCenter.com
- Ford restates results for 5 years, narrows Q3 loss — Reuters: Business
- SCM posts $3.9M loss in Q3 — Latest news from San Francisco Business Times
- Critical Path posts $5.6M loss in Q3 — bizjournals.com Banking & Financial Services:Commercial Banking headlines
- NewPage posts loss in Q3 — Latest news from Dayton Business Journal
- Akeena Solar posts Q3 loss despite higher revenue — Latest news from Silicon Valley/San Jose Business Journal
- Interra posts loss on Myanmar writedown — Business Times Online - Companies News
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Genelabs reports lower Q3 loss — Latest news from San Francisco Business Times
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Abbott's Humira Positive in 2 Studies
- Kos' Swan Song